In this context, the critical protective role of CD9 on lung inflammation and emphysema has been reported; for example, CD9 deficiency has been reported to enhance macrophage activation in vitro enormously and aggravate lung inflammation, as well as in vivo, through being induced by lipopolysaccharide (LPS) stimulation [38,40,41]. The gene discussed is CD9; the disease is inflammation.